The purpose of the present study was to investigate the effect of
luteolin on the angiogenesis and invasion of
breast cancer cells. MTT assay was used to examine
breast cancer proliferation. The chick chorioallantoic membrane model was used to assess the
angiogenesis effect. Wound healing assay was used to assess cell invasion ability. Western blot was used to analyze Bcl-2, AEG-1 and MMP-2 expression levels. The results showed
luteolin inhibited MCF-7 cells proliferation in a dose- and time-dependent manner, and the expression of Bcl-2
protein was decreased.
Luteolin had a strong anti-angiogenesis of chick chorioallantoic membrane.
After treatment of MCF-7 cells with
luteolin at 60 μmol/L for 48 h, migration rate was reduced by 71.07% compared with control (P < 0.01).
After treatment of MCF-7 cells with
luteolin at 60 μmol/L for 48 h, the expression of AEG-1 and MMP-2 was reduced by 82.34% (P < 0.05) and 85.70% (P < 0.05) respectively, compared with control. In conclusion, the results suggest that
luteolin can inhibit the proliferation of
breast cancer cells, and suppress the expression of Bcl-2. Furthermore,
luteolin has strong anti-angiogenesis of chick chorioallantoic membrane and anti-invasive activity on
breast cancer cells, and down-regulates the expression of AEG-1 and MMP-2.